| Gleason 7 (3+4) mean ± SD or n/N (%) | Gleason 7 (4+3) mean ± SD or n/N (%) | p value | |
| Age (years) | 64.3 ± 6.7 | 62.9 ± 10.6 | 0.38 |
| Preoperative serum PSA | 11.0 ± 3.3 | 11.8 ± 6.05 | 0.01 |
| ≤ 4,00ng/ml | 01/39 (03) | 01/16 (06) | 0.04 |
| > 4,00 and ≤ 9,99ng/ml | 28/39 (72) | 05/16 (32) | |
| > 9,99ng/ml | 10/39 (26) | 10/16 (62) | |
| Percentage of gland involvement by carcinoma | 16 ± 11.4 | 19 ± 11.7 | 0.29 |
| ≤ 10% | 27/76 (23) | 07/30 (35) | 0.14 |
| > 10% and ≤ 20% | 22/76 (29) | 09/30 (30) | |
| > 20% and ≤ 30% | 20/76 (26) | 07/30 (23) | |
| > 30% and ≤ 40% | 03/76 (04) | 06/30 (20) | |
| > 60% and ≤ 80% | 07/76 (05) | 01/30 (03) | |
| Tumor volume (ml) | 12.0 ± 3.48 | 12.0 ± 3.47 | 0.6 |
| Positive circumferential surgical margin | 18/76 (23) | 09/30 (30) | 0.3 |
| Positive basal surgical margin | 04/76 (05) | 03/30 (10) | 0.3 |
| Positive apical surgical margin | 02/76 (03) | 02/30 (07) | 0.3 |
| Extraprostatic extension | 15/76 (20) | 11/30 (38) | 0.04 |
| Seminal vesicle invasion | 03/76 (04) | 05/30 (17) | 0.02 |
| Tertiary Gleason 5 | 07/76 (09) | 02/30 (07) | 0.8 |